Methoxyphenylacetic Acid (MPAA), particularly the 2-methoxy and 4-methoxy variants, has become a cornerstone in the synthesis of diverse pharmaceuticals, including NSAIDs and dermatological treatments. The global demand is shifting towards ultra-high purity grades (>99.5%) to reduce byproduct toxicity in final drug formulations.
Gentolex is leading the transition to "China Factory 4.0." By integrating IoT monitoring and automated flow chemistry, we ensure supply chain resilience. Our 250,000 sqm facility provides scalable, cost-effective solutions while maintaining international cGMP standards.
Modern B2B procurement for MPAA now prioritizes Transparency and Compliance. Companies in Europe and North America require complete documentation, including REACH registration, SDS, and COA, to navigate increasingly stringent environmental regulations.
An overall factory construction area of 250,000 square meters under international standard to offer flexible, scalable and cost-effective solutions.
Gentolex offers an extensive range of APIs and intermediates for development study and commercial application with cGMP standard from long-term collaborations. Documents and Certificates are supported to customers worldwide.
For those clients who prefer to avoid the complexity of dealing with multiple points of contact, we provide extra customized procurement services with the most superior and comprehensive supply chain sources.
Gentolexβs goal is to create opportunities connecting the world with better services and guaranteed products. Up to date, Gentolex Group has been serving customers from more than 10 countries, specially, representatives are established in Mexico and South Africa. Our main services focus on supplying peptides APIs and Custom Peptides, FDF license out, Technical Support & Consultation, Product Line and Lab Setup, Sourcing & Supply Chain Solutions.
High-purity Methoxyphenylacetic Acid is vital for startup biotechs in Boston and San Francisco for rapid prototyping of novel CNS active compounds.
Our "Green Synthesis" protocols for MPAA align with EU environmental mandates, reducing solvent waste by 40% compared to traditional methods.
Leveraging China's industrial infrastructure to provide bulk quantities of intermediates for generic drug manufacturers in India and SE Asia.
Composition: Thr-Lys-Pro-Arg-Pro-Gly-Pro. Focused on neuropharmacological research and endogenous peptide derivatives.
Providing high-quality TΞ²4 peptide API solutions for biotechnology and pharmaceutical research organizations.
A synthetic pentadecapeptide gaining attention for tissue repair, angiogenesis, and inflammatory regulation.
Mitochondria-targeting tetrapeptide designed to stabilize mitochondrial structure and support bioenergetics.
Q: What is the typical purity level of your Methoxyphenylacetic Acid?
A: Our standard commercial grade is β₯99.0%, with pharmaceutical-grade options reaching β₯99.8% purity, verified by HPLC and GC analysis.
Q: How does Gentolex ensure supply chain stability during global disruptions?
A: We utilize a dual-sourcing strategy for raw materials and maintain high-volume buffer stocks in our 250,000 sqm facility to mitigate logistical delays.
Q: Can you provide customized particle size specifications for MPAA?
A: Yes, our advanced processing units can micronize or granulate the product according to specific formulation requirements for downstream synthesis.
Q: Do you offer technical consultation for lab setup?
A: Absolutely. Gentolex provides comprehensive Technical Support & Consultation, including product line and lab setup services for new manufacturing ventures.
